SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) March 17, 1998
BIOCONTROL TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-10822 25-1229323
(State of other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
300 Indian Springs Road, Indiana, Pennsylvania 15701
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (412) 349-1811
_________________________________________________________________
(Former name or former address,
if changes since last report.)
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
On March 17, 1998 Biocontrol Technology, Inc.
(NASDAQ:BICO) announced that all necessary information has now
been supplied to complete the Technical File submitted in late
February to its Notified Body, TUV Rheinland Product Safety GmbH,
Germany. The Technical File is the final step in obtaining the
CE Mark for the Diasensor 1000 noninvasive glucose sensor to be
marketed in Europe.
Item 6. Resignation of Registrant's Directors.
Not Applicable
Item 7. Financial Statement, Pro Forma Financial Information
and Exhibits.
(a) Financial Statements and Businesses Acquired - Not
Applicable.
(b) Pro Forma Financial Information - Not Applicable.
(c) Exhibits - Press Release.
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act
of 1934, the Registrant has duly caused this Report to be signed
on its behalf by the undersigned hereunto duly authorized.
BIOCONTROL TECHNOLOGY, INC.
by /s/ Fred E. Cooper
Fred E. Cooper, CEO
DATED: March 17, 1998
BICO
BIOCONTROL TECHNOLOGY, INC
2275 Swallow Hill Road, Building 2500
Pittsburgh, PA 15220
Press Release
For More Information, Call:
Investors Media
Diane McQuaide Susan Taylor
1.412.429.0673 phone 1.412.279.9455 phone
1.412.279.9690 fax 1.412.279.9447 fax
BIOCONTROL FINALIZES CE MARK TECHNICAL FILE
Pittsburgh, PA - March 17, 1998 - Biocontrol Technology,
Inc. (Nasdaq:BICO) announced today that all necessary information
has now been supplied to complete the Technical File submitted in
late February to its Notified Body, TUV Rheinland Product Safety
GmbH, Germany. The Technical File is the final step in obtaining
the CE Mark for the Diasensor 1000 noninvasive glucose sensor to
be marketed in Europe.
When achieved, the CE Mark on the Diasensor will signify
that the product meets the mandatory health and safety
requirements to be marketed in the 15-member European Union (EU)
with a diabetic population of approximately 15 million. The
first two steps in obtaining the CE Mark were completed by the
Company in October 1997 and January 1998 resulting in ISO 9001
registration for its Indiana, PA manufacturing and product
development facilities.
Biocontrol Technology, Inc. (www.bico.com) has its corporate
offices in Pittsburgh, PA and is involved in the development and
manufacture of biomedical devices and environmental products.
